免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Contour® next GEN 血糖监测系统

K号: K193407 · 2021-12-23

决定日期2021-12-23
产品代码NBW
咨询委员会CH 请注意,您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Contour® next GEN Blood Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Ascensia Diabetes Care. It received FDA 510(k) clearance on 2021-12-23 under 510(k) number K193407. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常见问题

What is the Contour® next GEN Blood Glucose Monitoring System?

Contour® next GEN Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2021-12-23. The listed applicant is Ascensia Diabetes Care. The 510(k) number is K193407.

When did Contour® next GEN Blood Glucose Monitoring System receive FDA 510(k) clearance?

Contour® next GEN Blood Glucose Monitoring System received FDA 510(k) clearance on 2021-12-23, under 510(k) number K193407.

Who is the listed applicant for Contour® next GEN Blood Glucose Monitoring System?

FDA 510(k)记录显示Ascensia Diabetes Care为申请人。这本身并不能确立该设备制造商的身份。

What is the FDA product code for Contour® next GEN Blood Glucose Monitoring System?

The FDA product code for Contour® next GEN Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Ascensia Diabetes Care为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NBW)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑